Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bRESCAP for prevention of delayed graft function after deceased donor kidney transplantation
NL-OMON51462Phase 2Recruiting
- Sponsor
- Nefro-NL
- Start
- May 2023
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial in acute kidney failure (AKF) comparing bRESCAP with Placebo (2 arms). Primary endpoint: Duration of delayed graft function. Started May 2023; status: recruiting.
02
Drugs
bovine intestinal alkaline phosphatase
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on NL-OMON51462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51462.